A bespoke CRISPR therapy suggests a blueprint for treating ‘N-of-1’ diseases
Bio Pharma Dive
MAY 15, 2025
A gene editing drug custom-made for a critically ill baby showed that, for some ultra-rare diseases, it’s possible to design and test a new CRISPR medicine in just a few months.
Let's personalize your content